Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Effect of digoxin on shocks in cardiac resynchronization therapy-defibrillator patients with coronary artery disease.

Adelstein E, Schwartzman D, Jain S, Bazaz R, Saba S.

Am J Cardiol. 2014 Mar 15;113(6):970-5. doi: 10.1016/j.amjcard.2013.12.007.

PMID:
24440327
2.

Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.

Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E; MADIT-CRT Executive Committee..

J Am Coll Cardiol. 2012 Jun 19;59(25):2366-73. doi: 10.1016/j.jacc.2012.01.065.

3.

The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).

Kutyifa V, Kloppe A, Zareba W, Solomon SD, McNitt S, Polonsky S, Barsheshet A, Merkely B, Lemke B, Nagy VK, Moss AJ, Goldenberg I.

J Am Coll Cardiol. 2013 Mar 5;61(9):936-44. doi: 10.1016/j.jacc.2012.11.051. Erratum in: J Am Coll Cardiol. 2013 Apr 2;61(13):1469.

4.

Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks.

Van Boven N, Bogaard K, Ruiter J, Kimman G, Theuns D, Kardys I, Umans V.

J Cardiovasc Electrophysiol. 2013 Mar;24(3):316-22. doi: 10.1111/jce.12037.

PMID:
23210664
5.
6.

Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.

Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML.

Am J Cardiol. 2010 Jan 1;105(1):105-11. doi: 10.1016/j.amjcard.2009.08.659.

PMID:
20102900
7.

Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.

Lee AY, Kutyifa V, Ruwald MH, McNitt S, Polonsky B, Zareba W, Moss AJ, Ruwald AC.

Heart Rhythm. 2015 Sep;12(9):2010-7. doi: 10.1016/j.hrthm.2015.05.016.

PMID:
26025322
8.

Appropriate therapies predict long-term mortality in primary and secondary prevention of sudden cardiac death.

Stabile G, D'Agostino C, Gallo P, Marrazzo N, Iuliano A, De Simone A, Turco P, Palella M, Donnici G, Ciardiello C, Napolitano G, Solimene F.

J Cardiovasc Med (Hagerstown). 2013 Feb;14(2):110-3. doi: 10.2459/JCM.0b013e3283511f5b.

PMID:
22367567
9.

Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias.

Manfredi JA, Al-Khatib SM, Shaw LK, Thomas L, Fogel RI, Padanilam B, Rardon D, Vatthyam R, Gemma LW, Golden K, Prystowsky EN.

Circ Arrhythm Electrophysiol. 2013 Apr;6(2):257-64. doi: 10.1161/CIRCEP.112.000214.

10.

Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.

Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F.

Circulation. 2006 Dec 19;114(25):2766-72.

11.

Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.

Kreuz J, Skowasch D, Horlbeck F, Atzinger C, Schrickel JW, Lorenzen H, Nickenig G, Schwab JO.

Am J Cardiol. 2013 May 1;111(9):1319-23. doi: 10.1016/j.amjcard.2013.01.277.

PMID:
23411108
12.

Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D.

Sebag FA, Lellouche N, Chen Z, Tritar A, O'Neill MD, Gill J, Wright M, Leclercq C, Rinaldi CA.

J Cardiovasc Electrophysiol. 2014 Dec;25(12):1368-75. doi: 10.1111/jce.12496.

PMID:
25066404
13.

Can QRS scoring predict left ventricular scar and clinical outcomes?

Rosengarten JA, Scott PA, Chiu OK, Shambrook JS, Curzen NP, Morgan JM.

Europace. 2013 Jul;15(7):1034-41. doi: 10.1093/europace/eut014.

14.

Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.

Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS.

Am J Cardiol. 2007 Jul 1;100(1):90-3.

PMID:
17599447
15.
16.
17.

Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.

Kreuz J, Horlbeck F, Schrickel J, Linhart M, Fimmers R, Mellert F, Nickenig G, Schwab JO.

Clin Cardiol. 2012 Sep;35(9):575-9. doi: 10.1002/clc.22018.

18.

Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.

Martinelli M, de Siqueira SF, Sternick EB, Rassi A Jr, Costa R, Ramires JA, Kalil Filho R.

Am J Cardiol. 2012 Oct 1;110(7):1040-5. doi: 10.1016/j.amjcard.2012.05.040.

PMID:
22727179
19.

Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.

van Boven N, Theuns D, Bogaard K, Ruiter J, Kimman G, Berman L, VAN DER Ploeg T, Kardys I, Umans V.

J Cardiovasc Electrophysiol. 2013 Oct;24(10):1116-22. doi: 10.1111/jce.12208.

PMID:
23889733
20.

Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.

Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.

Pacing Clin Electrophysiol. 2010 Jun 1;33(6):696-704. doi: 10.1111/j.1540-8159.2009.02669.x.

PMID:
20059719
Items per page

Supplemental Content

Support Center